Victory Square Technologies Reports Fiscal 2025 Results Highlighting Platform Scaling, Healthcare Infrastructure Growth and Portfolio Momentum

Victory Square Technologies Inc. (the Parent Company) reported audited fiscal 2025 results on May 1, 2026, confirming the financial performance previously highlighted by its primary operating subsidiary, Hydreight Technologies Inc., on April 30, 2026. The consolidated revenue for fiscal 2025 was $35.4 million, representing a 121% year-over-year increase driven almost entirely by Hydreight. Adjusted EBITDA reached $2.5 million, marking a significant turnaround from the prior year's $136K. Management reiterated forward revenue guidance of approximately $150 million for fiscal 2026. The news also highlighted portfolio developments including the launch of Pawsible Ventures' $10M fund and the distribution of Yocale.ai shares to shareholders.

• Confirmation vs. Surprise: This release is largely confirmatory. Hydreight Technologies (the main asset) released identical financial figures on April 30, 2026. The May 1 report serves as the official consolidated earnings for Victory Square but adds no new material financial data beyond what was already disseminated by the subsidiary one day prior.
• Guidance Validation: The $150 million revenue guidance for FY2026 was previously announced in February 2026 (NewsId: 52618). This report confirms the FY2025 actuals ($35.4M) that underpin this guidance, but does not raise or lower expectations.
• Risk Factor: The implied growth rate from $35.4M (FY25 Actual) to $150M (FY26 Guidance) is approximately 324%. For a risk-averse analyst, this represents a significant execution risk that has already been priced into the stock via the February announcement.
• Portfolio Updates: The distribution of Yocale.ai shares and Pawsible Ventures launch are positive operational milestones but do not materially impact immediate cash flow or valuation multiples compared to Hydreight's core performance.

• Company Overview: Victory Square Technologies Inc. is a holding company focused on healthcare infrastructure and digital health platforms. Its primary operating subsidiary is Hydreight Technologies Inc., which drives the majority of revenue and profitability.
• Flagship Project: Hydreight's VSDHOne platform, a national telehealth and pharmacy network enabling brands to launch direct-to-consumer healthcare services across all 50 U.S. states.
• Development Status: The platform has scaled to over 11,000 licenses (as of Q1 2026) and processed over 1.3 million product orders in 2025. It is currently expanding into new verticals including GLP-1 weight management, STI testing, and peptide delivery.